Amides

<p>L-Aspartic acid beta-naphthylamide is a dietary amino acid that is metabolized to oxaloacetate in the liver. This metabolite is then converted to aspartate and glutamate, which are both important for brain functions. L-Aspartic acid beta-naphthylamide has been shown to have regulatory effects on peptide hormones, such as inhibiting the synthesis of angiotensin II and vasopressin in rats. L-Aspartic acid beta-naphthylamide also has anti-cancer properties, which may be due to its ability to inhibit the growth of cancer cells by hydrolyzing proteins and enzymes involved in fatty acid synthesis.</p>

<p>(+/-)-tert-Butylsulphonamide is a synthetic molecule that is a functional group with two aryl halides. It has been shown to inhibit the mitochondrial protein synthesis by preventing the nitrosylation of tyrosine residues in proteins. This inhibition prevents the production of growth factors and other bioactive molecules, leading to an increase in the cell's sensitivity to genotoxic agents. (+/-)-tert-Butylsulphonamide has also been shown to inhibit viral replication and infectivity by targeting viral RNA polymerase, which is responsible for viral transcription. The chloride anion present in (+/-)-tert-butylsulphonamide may have an inhibitory effect on viruses with a low pH environment, such as naphthalene or carbonic acid; however, it does not affect viruses with a neutral pH.END&gt;</p>

<p>DL-Leucine amide hydrochloride is a fine chemical that can be used as a building block for research chemicals, as a reagent for the preparation of other compounds, and as a speciality chemical. DL-Leucine amide hydrochloride has been shown to be effective in the synthesis of complex compounds. The compound is also versatile and can be used as an intermediate or scaffold in the synthesis of other compounds. DL-Leucine amide hydrochloride is useful in reactions such as condensation, substitution, elimination, and Grignard reactions. It is also used in peptide synthesis and polymerization reactions.</p>

<p>The Val-Cit-PAB linker is an activated peptide linker that is cleaved by cathepsin B. It enables the selective intracellular release of attached drugs in ADC applications.</p>

<p>5-Amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide is an experimental compound that is used in the industrial preparation of pharmaceuticals and agricultural chemicals. It has a molecular weight of 191.14 g/mol. The crystallization process involves the use of ethanol to create supersaturation and then cooling to induce crystallization. This compound can be synthesized by an iodination reaction with x-ray irradiation at low temperatures.</p>

<p>N-(Phenylsulfonyl)palmitamide is a versatile building block that can be used to create complex compounds for research. CAS No. is 527-87-2 and it is a reagent and speciality chemical with high quality. It is also useful as a reaction component in the synthesis of other compounds, or as a scaffold for the synthesis of new derivatives.</p>

<p>4-Hydroperoxycyclophosphamide (4-HPPC) is a cytotoxic agent with anti-cancer properties. It is a prodrug that is converted to 4-hydroxycyclophosphamide, the active form of the drug, by hydrolases in cells. The cytotoxicity of 4-HPPC has been demonstrated using a model system of human erythrocytes and HL60 cells. This drug also has an effect on tumor growth and metastasis, as well as on bowel disease. Rats treated with 4-HPPC showed decreased levels of blood glucose, increased glutathione peroxidase activity, and a decrease in the number of colonic tumors after only one dose. The low-dose group had improved mitochondrial membrane potential and an increase in cell factor receptor activity. These results indicate that 4-HPPC may be a useful anti-cancer compound for treating various types of cancer including colon cancer.</p>

<p>Please enquire for more information about 2-Indol-3-yl-2-oxo-N-(3-(1,1,2,2-tetrafluoroethoxy)phenyl)ethanamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Quinfamide is a polyunsaturated compound that contains a cevimeline hydrochloride molecule. It is used to treat bowel disease, usually in combination with other drugs. Quinfamide has been shown to have specific treatment effects on the symptoms of inflammatory bowel disease (IBD) when given at doses of 400-800 mg per day for up to 12 weeks. This drug can also be used as an analog for 5-membered heteroaryl compounds, such as benzalkonium chloride, which are also used to treat bowel disease. Quinfamide has been shown to have anti-inflammatory properties and may work by inhibiting fatty acid synthesis or by reducing the number of neutrophils in the gut.</p>

<p>N-(2-indol-3-ylethyl)benzamide (4-AIBA) is a functional, health functional food. It has shown anticancer activity in a human colon carcinoma cell line, and it inhibits the production of nitrous oxide from inducible nitric oxide synthase, which is important for tumor invasion. 4-AIBA also inhibits tyrosinase activity, an enzyme that is involved in melanin synthesis. This inhibition may be beneficial to skin conditions such as acne or pigmentation disorders. The compound also inhibits the degranulation of mast cells and stimulates cell proliferation in rat mesenteric lymph nodes.</p>

<p>Thioacetamide is a chemical compound that has been used as a model system to study apoptosis. It is also known to cause injury and biochemical changes in cells. Thioacetamide is metabolized by cytochrome P450 enzymes and conjugated with glucuronic acid, which prevents it from binding to DNA or protein. The oxidation of thioacetamide by cytochrome P450 enzymes leads to the formation of reactive oxygen species that may cause DNA damage. Apoptosis induced by thioacetamide has been shown to be mediated through the mitochondrial pathway, which involves the release of cytochrome C, activation of caspase-9, and cleavage of poly (ADP-ribose) polymerase (PARP). Thioacetamide also inhibits sorbitol dehydrogenase activity, which leads to an accumulation of sorbitol in cells. This accumulation can activate transcriptional factors such as nuclear factor kappa B (NF-κB), leading to</p>

<p>Tiaramide hydrochloride is a nonsteroidal anti-inflammatory drug that inhibits the production of prostaglandins. It has been shown to have an anti-inflammatory activity in bowel disease and inflammatory bowel disease, which may be due to its ability to inhibit the production of prostaglandin synthesis. Tiaramide hydrochloride is also a coumarin derivative that can form an n-oxide on exposure to air or light. It has been used in tissue culture experiments as a nanoparticulate composition, where it was found to have a dose-dependent effect on cell viability and proliferation. Tiaramide hydrochloride has been used in sample preparation for human serum and rat liver microsomes, where it showed a hydroxyl group that binds with fatty acids.</p>

<p>2-Chloro-N-(3,5-dichlorophenyl)acetamide is a stabilized, crystalline compound. It has a planar structure with an amide bond and hydrogen bonds. The 2-chloro group is bonded to the nitrogen atom of the acetamide group. The 3,5-dichlorophenyl group is bonded to the carbon atom of the acetamide group. The chlorine atoms are in a planar configuration with adjacent chlorine atoms forming a skeletal arrangement. This chemical is used as an intermediate for other compounds.</p>

<p>N-Benzylbenzamide is a molecule that contains an amide group, which is considered to be a hydrogen bond acceptor. The amine group of this compound can also act as a hydrogen bond donor. It has been shown to inhibit the activity of tyrosinase, which is an enzyme responsible for the production of melanin in melanocytes. N-Benzylbenzamide has been shown to have a molecular mechanism similar to that of hydroquinone and other phenolic compounds. In addition, it has been found to decrease microvessel density and inhibit the growth of cancer cells in vitro. This compound is not yet approved for use as a drug but may be used in future research studies as an alternative treatment for cancer.</p>

<p>Sodium diformylamide is a chemical compound that belongs to the class of amides. It has been shown to inhibit the activity of a number of enzymes including alkanoic acid, inorganic acid, and amide. It has also shown promising results in the prevention and treatment of metabolic disorders such as hepatitis. The asymmetric synthesis of this compound is achieved through the use of trifluoroacetic acid and nitrogen atoms. The biological properties of sodium diformylamide have not yet been fully researched but it has been found to have integrin receptor-binding properties.</p>

<p>N-[(3S)-2,5-Dioxotetrahydro-3-furanyl]-2,2,2-trifluoroacetamide is a boronic acid that has been used to synthesize polymers. This compound is of interest for the synthesis of hydrophobic amino acids such as threonine and lysine. The high yield and functionalisation of this molecule make it deserving of further investigation.</p>

<p>2-(5-Bromo-1H-indol-3-yl)acetamide is a high quality, reagent, complex compound, useful intermediate and fine chemical. It is also a useful scaffold or building block for the synthesis of speciality chemicals. 2-(5-Bromo-1H-indol-3-yl)acetamide is used in research and development as a versatile building block for the synthesis of new compounds. The CAS number for this compound is 196081-79-5.</p>

<p>5-Methyl-2-nitrobenzamide is a compound that has antiproliferative activity and is used as an anticancer drug. This drug inhibits the polymerization of the protein tubulin in cancer cells, thereby inhibiting cell division. It also inhibits the growth of certain tumor cell lines in vitro. 5-Methyl-2-nitrobenzamide was found to inhibit the proliferation of human ovarian carcinoma cells by binding to DNA, preventing transcription and replication of genetic information. In addition, this agent binds to tubulin and prevents its polymerization, leading to inhibition of cell division.</p>

<p>L-Histidine beta-naphthylamide is an allosteric activator of the imidazole group of histidine. It has been shown to regulate sequences and functional groups in subtilisin. L-Histidine beta-naphthylamide binds to the benzyl ester and regulatory allosteric site on the enzyme, which is located between the active site and the substrate binding site. The binding of this molecule stabilizes a transition state intermediate that would otherwise be too reactive to form products.</p>

<p>N-Allyl-N-Ethylheptadecafluorooctanesulphonamide is a chemical substance that belongs to the group of sulfonates. It is an oily liquid with a boiling point of about 160°C, and is soluble in water. N-Allyl-N-Ethylheptadecafluorooctanesulphonamide has been used as a component of mixtures, such as cleaning agents and cosmetics. The chemical properties of this substance are not well studied due to its limited use.</p>

<p>2-Phenylacetamide is a solvent that can be used as a component in alkylation reactions. It is commonly used as a component of chlorinated solvents and has been shown to catalyze the reaction with benzyl chloride. 2-Phenylacetamide can be used to produce solar cells by sensitizing the surface of silicon wafers with this solvent. Researchers have also studied the alkylation reaction of phenylacetamide with methyl iodide and benzyl chloride, which can be carried out at room temperature and does not require any catalyst. This reaction was found to proceed well under gas chromatographic conditions.</p>

<p>3-Ethoxybenzamide is a crystalline compound that can form complexes with metal ions. It has been shown to inhibit bacterial growth by binding to the enzyme thiourea, which is essential for the biosynthesis of thiamine. 3-Ethoxybenzamide also inhibits the production of hydrogen sulfide, which is produced by bacteria and a cause of foul odors. 3-Ethoxybenzamide has been shown to have antibacterial activity against Gram-positive bacteria such as Staphylococcus aureus and Streptococcus pyogenes. 3-Ethoxybenzamide also inhibits the growth of Gram-negative bacteria such as Escherichia coli and Salmonella typhimurium. This compound has also been shown to have anti-inflammatory activities through its ability to inhibit prostaglandin synthesis in mice.</p>

<p>N-(3,5-Dichloro-4-Pyridinyl)-2-[1-(4-Fluorobenzyl)-5-Hydroxy-1H-Indol-3-Yl]-2-Oxoacetamide is a prodrug that is metabolized to the active form in vivo. It inhibits the activity of cyclic nucleotide phosphodiesterase (PDE), an enzyme that catalyzes the conversion of cAMP to AMP and PDE, which catalyzes the conversion of cGMP to GMP. This drug has been shown to have a potent inhibitory effect on inflammatory cytokines such as IL-6 and TNFα. N-(3,5-Dichloro-4-pyridinyl)-2-[1-(4 fluorobenzyl)-5 hydroxy 1H indol 3 yl]-2 oxoacetamide has been shown to be effective for treatment of inflammatory diseases such as bronch</p>

<p>6-Methylnicotinamide is a transport inhibitor that prevents the uptake of fatty acids and growth factors into cells. It has been shown to inhibit the activity of glutamate receptors by blocking the interaction between these receptors and their binding partners, which are called co-agonists. 6-Methylnicotinamide has also been shown to inhibit the synthesis of virus proteins in vitro and in vivo. There is a lack of evidence on its safety profile. 6-Methylnicotinamide may be used to treat hepatitis C and colorectal carcinoma.</p>

<p>N-[(8-Fluoro-2,3-Dihydro-1-Methyl-5-Phenyl-1H-1,4-Benzodiazepin-2-Yl)Methyl]-3-Furancarboxamide is a hydrophobic, implanting drug with an iontophoresis device. It has been shown to have therapeutic effects in cancer. The drug is a targetable molecule that can be used for diagnostic purposes and the treatment of various cancers. N-[(8-Fluoro-2,3-Dihydro-1,5 -Phenyl 1H -1,4 Benzodiazepin 2 Yl) Methyl] 3 Furancarboxamide has been shown to inhibit cell proliferation by blocking the synthesis of proteins required for DNA replication and also inhibits the activity of protein kinase C.</p>

<p>N-[2-Iodoethyl]trifluoroacetamide is a reactive alkylating agent that is used in the synthesis of biologically active molecules. It reacts with lysines, tryptic and other amino acids to form covalent bonds, which can be cleaved by hydrolysis. The compound also reacts with sulfhydryl groups to produce sulfonium ions, which react with the thiol group at position C6 on the sarcoplasmic reticulum Ca2+ -ATPase to inhibit muscle contraction. N-[2-Iodoethyl]trifluoroacetamide has been shown to cause allergic reactions in rats, mice, and guinea pigs. This drug has also been observed to have an effect on the central nervous system when administered at high doses.</p>

<p>Tropicamide is a cholinergic agent that is used as a short-term mydriatic, or eye dilator, for diagnostic purposes. It belongs to the group of nonsteroidal anti-inflammatory drugs and has been shown to have a stable complex with benzalkonium chloride. Tropicamide has been shown to affect the signal pathways in cells, leading to an increase in IL-2 receptor expression. This drug also affects locomotor activity and has been studied as a potential treatment for murine sarcoma virus. Tropicamide is administered intravenously and can cause side effects such as blurred vision, nausea, vomiting and convulsions. Tropicamide may be given together with phenylephrine in order to reduce these side effects.</p>

<p>Please enquire for more information about (3-(2,6-dichlorophenyl)-5-methylisoxazol-4-yl)-N-(2-indol-3-ylethyl)formamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Please enquire for more information about N-(4-methylthio(3H-2,3,5-triazolyl))-3-phenylprop-2-enamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Veratramide is a levorotatory, vanillic acid that has been synthesized by hydrolysis of esomeprazole. It is an ester of vanillic acid and hydrochloric acid. The cis-isomer is the more active form. Veratramide has been shown to be a prodrug for cisplatin, which is used in the treatment of cancer. Veratramide can also be metabolized to acetyl derivatives or flavonoids such as vitexin and metformin hydrochloride, which have anti-diabetic effects. Veratramide also binds to chloride ion channels, hypervalent ions (e.g., AlCl3), and quaternary ammonium salts (e.g., tetraethylammonium chloride).</p>

<p>N,N'-Dimethyl benzamide (DMAB) is an aryl halide that reacts with hydrogen to form the corresponding carbonyl group. The reaction solution of DMAB and hydrogen gas produces a chemical structure that resembles a hydrogen bond. DMAB has been shown to have anti-inflammatory effects in animals with inflammatory diseases. It has also been studied for its ability to inhibit the formation of amyloid plaque, which is associated with Alzheimer's disease. In addition, DMAB has been shown to have therapeutic effects against boron nitride and amides.<br>The crystal structure of DMAB can be found in both crystalline polymorphs: monoclinic and triclinic. The triclinic form is stable at room temperature and pressure, while the monoclinic form is only stable at higher temperatures. The monoclinic form is more soluble than the triclinic form, as it contains fewer hydrogen bonds between</p>

<p>2'-Hydroxy-5'-nitrohexadecanamide is a synthetic fatty acid derivative that inhibits lysosomal hydrolase, which is an enzyme that breaks down cellular lipids. This compound can be used as a diagnostic agent for the detection of certain types of cancer. 2'-Hydroxy-5'-nitrohexadecanamide reacts with the magnesium ion in the lysosome to form an insoluble precipitate, which then settles to the bottom of the test tube, allowing for easy detection of cells with high levels of lysosomal hydrolase.</p>

<p>μ-opioid receptor agonist; calcium channel inhibitor; anti-diarrheal</p>

<p>Please enquire for more information about (4-(2-Fluorophenyl)piperazinyl)-N-propylformamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>(2R)-1-(Phenylmethyl)-N-[3-(spiro[isobenzofuran-1(3H),4'-piperidin]-1-yl)propyl-2-pyrrolidinecarboxamide HCl is an endogenous opioid that has been shown to have antidepressant-like effects. It can bind to γ-aminobutyric acid (GABA) receptors, catecholamine receptors, and nociceptin receptors. This drug also has anti-cancer properties and may be used for the treatment of autoimmune diseases. The interaction of this drug with other drugs is not well understood, but it has been shown to modulate the effects of opioids and increase the aversive nature of some substances.</p>

<p>Please enquire for more information about (2-Aminophenyl)-N-((3,4-dimethoxyphenyl)methyl)formamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>N-Allyl-N-(4-cyano-2-chlorophenyl)acetamide is a high quality reagent that has been used as an intermediate in the synthesis of fine chemicals, useful scaffolds and building blocks. It is also a versatile building block that can be used to synthesize high quality compounds with a wide range of functionalities. N-Allyl-N-(4-cyano-2-chlorophenyl)acetamide is a speciality chemical that can be used for research purposes. This compound has been shown to produce reactions with other compounds, such as nitrobenzene, to generate useful products.</p>

<p>This compound is a recyclable, multicomponent, element analysis, element, diversity and catalyzed reaction that yields high purity products with high yields. The catalyst is reusable and the NMR data are reproducible.</p>

<p>Please enquire for more information about LY2112688 trifluoroacetate including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>(S,E)-3-(6-Bromopyridin-2-yl)-2-cyano-N-(1-phenylethyl)acrylamide (MBI-23) is a potential antineoplastic agent that has been shown to induce regression of bladder cancer in mice. MBI-23 induces apoptosis by inhibiting the proliferation of cancer cells and inducing differentiation of cancer stem cells. It is also shown to inhibit tumor growth and progression in glioma and prostate cancer models. MBI-23 binds to the KDR receptor subtype, which is activated by organic acids and inhibited by inorganic compounds. This binding leads to constitutive activation of the KDR receptor, thereby inducing apoptosis. The tautomers and stereoisomers of MBI-23 have not been fully elucidated yet.</p>

<p>Please enquire for more information about 2-Chloro-N-(3-chloro-4-methylphenyl)propanamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Heptadecafluoro-N,N-Bis(2-Hydroxyethyl)Octanesulphonamide is a lubricant that is used in the manufacture of polyester films. It is insoluble and has excellent compressive properties. This compound is soluble in both organic solvents and water, and can be applied as a transfer agent or to obviate the need for a separate lubricant. Heptadecafluoro-N,N-Bis(2-Hydroxyethyl)Octanesulphonamide is an inorganic material that does not react with other materials. It also has good deformation resistance and low hardness. The particle size of this compound is between 5 and 10 microns.</p>

<p>Please enquire for more information about (3-(2,6-dichlorophenyl)-5-methylisoxazol-4-yl)-N-(2,5-dimethoxyphenyl)formamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Please enquire for more information about N-amino-2-(4-bromo-3,5-dimethylphenoxy)ethanamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>2,4,6-Trimethoxybenzamide is a triggered compound that reacts with lithium to form an efficient regiospecific lithium 2,4,6-trimethoxybenzamide complex. This reaction occurs at low temperatures and has been shown to be more efficient than other methods for the synthesis of acridones. The reaction has not been shown to be reversible and requires the use of a strong base such as lithium.</p>

<p>Prothionamide is a drug that belongs to the group of drugs called sulfonamides. It is used to treat bowel disease by inhibiting the growth of bacteria and fungi. Prothionamide inhibits bacterial growth by binding to bacterial DNA and preventing it from synthesizing new proteins. This drug also has a matrix effect, which means that it binds to the inside of the bacterial cell wall and prevents the production of new cells, leading to cell death. Prothionamide has been shown to be effective against tuberculosis in mice, although there are few data on its use in humans. The most common side effects associated with prothionamide are nausea and vomiting.</p>

<p>Hydroxyflutamide is an anti-androgen drug that belongs to the group of nonsteroidal anti-androgens. It has been shown to bind to the androgen receptor with high affinity and inhibit the growth of cancer cells in vitro. Hydroxyflutamide also has a strong antitumor response in vivo, which is due to its ability to inhibit cellular proliferation by binding to DNA polymerase during replication. The drug may also have some activity as an antineoplastic agent because it inhibits the growth of prostate cancer cells. However, hydroxyflutamide has never been tested on humans or animals, so its effects are unknown.</p>

<p>M06164 - Boc-Ala-NH2</p>